Ayr Wellness Inc. (OTCMKTS:AYRWF - Free Report) - Stock analysts at Seaport Res Ptn reduced their Q4 2024 earnings per share (EPS) estimates for Ayr Wellness in a research report issued on Sunday, November 24th. Seaport Res Ptn analyst S. Randhawa now forecasts that the company will earn ($0.26) per share for the quarter, down from their previous forecast of ($0.24). The consensus estimate for Ayr Wellness' current full-year earnings is ($1.30) per share. Seaport Res Ptn also issued estimates for Ayr Wellness' Q1 2025 earnings at ($0.24) EPS, Q2 2025 earnings at ($0.22) EPS, Q3 2025 earnings at ($0.21) EPS, Q4 2025 earnings at ($0.20) EPS and FY2025 earnings at ($0.87) EPS.
Other research analysts have also recently issued reports about the company. Roth Capital upgraded Ayr Wellness to a "strong-buy" rating in a research note on Friday, November 8th. Atb Cap Markets downgraded Ayr Wellness from a "hold" rating to a "strong sell" rating in a report on Wednesday, November 13th. Finally, Roth Mkm decreased their price target on Ayr Wellness from $3.50 to $3.00 and set a "buy" rating for the company in a research note on Thursday, November 14th.
View Our Latest Stock Analysis on Ayr Wellness
Ayr Wellness Price Performance
Shares of AYRWF traded up $0.02 during trading hours on Wednesday, reaching $0.69. The stock had a trading volume of 525,225 shares, compared to its average volume of 679,466. Ayr Wellness has a 12 month low of $0.62 and a 12 month high of $4.09. The company has a quick ratio of 0.58, a current ratio of 1.59 and a debt-to-equity ratio of 0.76. The company's 50-day moving average is $1.63 and its two-hundred day moving average is $1.90.
Ayr Wellness Company Profile
(
Get Free Report)
Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.
See Also
Before you consider Ayr Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ayr Wellness wasn't on the list.
While Ayr Wellness currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
